Literature DB >> 16848048

Panton-Valentine leukocidin genes in Staphylococcus aureus.

Damian C Melles, Willem B van Leeuwen, Hélène A M Boelens, Justine K Peeters, Henri A Verbrugh, Alex van Belkum.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16848048      PMCID: PMC3375734          DOI: 10.3201/eid1207.050865

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
The pathogenicity of Staphylococcus aureus depends on various bacterial surface components and extracellular proteins. However, the precise role of single virulence determinants in relation to infection is hard to establish. The frequent recovery of staphylococcal isolates that produce leukocidal toxins from patients with deep skin and soft tissue infections, particularly furunculosis, cutaneous abscesses, and severe necrotizing pneumonia, suggests that the Panton-Valentine leukocidin (PVL) is 1 such virulence factor that has a major role in pathogenicity (–). In 1932, Panton and Valentine described PVL as a virulence factor belonging to the family of synergohymenotropic toxins (). These toxins form pores in the membrane of host defense cells by synergistic action of 2 secretory proteins, designated LukS-PV and LukF-PV, which are encoded by 2 cotranscribed genes of a prophage integrated in the S. aureus chromosome (). PVL is mostly associated with community-acquired methicillin-resistant S. aureus (MRSA) infections and distinguishable from nosocomial MRSA by nonmultidrug resistance and carriage of the type IV staphylococcal chromosome cassette element (SCCmec type IV) (,). Despite the presumed importance of PVL as a virulence factor, few data are available on its prevalence among S. aureus isolates from the nares of healthy persons compared with stains isolated from infections. This lack of data led us to investigate the frequency of PVL gene–positive S. aureus strains obtained from the nares of healthy carriers in the community. For this purpose, a single polymerase chain reaction method was used to detect both lukS-PV and lukF-PV genes (). In a previous study, the population structure of S. aureus, isolated from the nares of healthy persons in the Rotterdam area, the Netherlands, was elucidated (). Strains were obtained from healthy children (<19 years) and elderly persons (>55 years). Invasive strains (blood culture, skin and soft tissue infections, and impetigo isolates) were included in this study (Table). All carriage and clinical isolates (n = 1,033) were mecA negative. We used the same strain collection to study the PVL prevalence in carriage and invasive isolates of S. aureus from a single geographic region.
Table

Panton-Valentine Leukocidin (PVL) distribution among carriage and invasive isolates per genetic cluster of Staphylococcus aureus

Amplified fragment length polymorphism cluster
I
(n = 462)
II
(n= 261)
III
(n = 208)
IVa
(n = 62)
IVb
(n = 40)
Total
(N = 1,033)
PVL positive, n (%)
Carriage isolates
(n = 829)111025 (0.6)*
Bacteremia isolates
(n = 146)110013 (2.1)†
Soft tissue infection isolates
(n = 18)150107 (38.9)‡
Impetigo isolates
(n = 40)000000 (0.0)
Total
(N = 1,033)3 (0.6)§7 (2.7)1 (0.5)¶1 (1.6)3 (7.5)#15 (1.5)
MLST** data of PVL-positive isolatesCC 1, n = 2
CC 8, n = 1CC 30, n = 7CC 45, n = 1CC 22, n = 1CC 121, n = 3

‡versus *Fisher exact test (2-sided); p<0.0001.
‡versus †Fisher exact test (2-sided); p<0.0001.
#versus §Fisher exact test (2-sided); p = 0.0079.
#versus ¶Fisher exact test (2-sided); p = 0.0140.
**MLST, multilocus sequence typing; CC, clonal complex.

‡versus *Fisher exact test (2-sided); p<0.0001.
‡versus †Fisher exact test (2-sided); p<0.0001.
#versus §Fisher exact test (2-sided); p = 0.0079.
#versus ¶Fisher exact test (2-sided); p = 0.0140.
**MLST, multilocus sequence typing; CC, clonal complex. Five PVL-positive S. aureus strains (0.6%) were found in the carriage group (n = 829), and 3 (2.1%) of 146 blood-culture isolates carried the PVL gene (Table). This finding is in agreement with previously reported low PVL prevalences by Prevost et al. (0% in 31 carriage isolates and 1.4% in 69 blood-culture isolates) and Von Eiff et al. (1.4% in 210 carriage isolates and 0.9% in 219 blood-culture isolates) (,). However, a higher prevalence of PVL (38.9%) was found in S. aureus strains causing abscesses and arthritis (Fisher exact test, p <0.0001) (). This finding is also in agreement with the proposed involvement of PVL in severe and invasive (soft tissue) staphylococcal infections (–). No significant differences were found in the presence of PVL when carriage isolates were compared with invasive blood-culture isolates. PVL was found in each major genomic amplified fragment length polymorphism (AFLP) cluster, indicating that PVL has been introduced in distinct phylogenetic subpopulations of S. aureus (Figure). Multilocus sequence typing analysis of a subset of the strain collection showed that the 15 PVL-positive strains were within clonal complex (CC) 30 (n = 7), CC 121 (n = 3), CC 1 (n = 2), CC 8 (n = 1), CC 22 (n = 1), and CC 45 (n = 1) (Table) (). Although PVL was found among several staphylococcal genotypes, it was slightly overrepresented in AFLP cluster IVb (CC 121) compared with major clusters I and III. Whether the prevalence of PVL in carriage- and blood-culture isolates is higher and differs among distinct genetic clusters of S. aureus in countries with endemic CA-MRSA has to be investigated further.
Figure

Principal component analysis of amplified fragment length polymorphism (AFLP) data of 1,033 Staphylococcus aureus strains. The different cubes (plotted in 3-dimensional space) represent every strain in the study. Each axis represents the score calculated for that strain on each principle component. The 4 circles indicate the different genetic AFLP clusters. Cluster IV could be subdivided in 2 minor clusters (). The percentages (below each cluster) indicate the relative number of Panton-Valentine leukocidin (PVL)-positive strains in each major AFLP cluster. The single PVL-positive strain in cluster III is not visible behind the gray cubes. Gray, PVL-gene negative; red, PVL-gene positive.

Principal component analysis of amplified fragment length polymorphism (AFLP) data of 1,033 Staphylococcus aureus strains. The different cubes (plotted in 3-dimensional space) represent every strain in the study. Each axis represents the score calculated for that strain on each principle component. The 4 circles indicate the different genetic AFLP clusters. Cluster IV could be subdivided in 2 minor clusters (). The percentages (below each cluster) indicate the relative number of Panton-Valentine leukocidin (PVL)-positive strains in each major AFLP cluster. The single PVL-positive strain in cluster III is not visible behind the gray cubes. Gray, PVL-gene negative; red, PVL-gene positive. In conclusion, we have shown that the PVL-encoding phage has entered distinct staphylococcal lineages, although its prevalence differs per clonal group. PVL is associated with skin and soft tissue infections but not with bacteremia, which suggests that PVL is not likely to be involved in the pathogenesis of bacteremia. Infections caused by PVL-positive S. aureus strains have been documented since the 1930s. Expansion and increased incidence of such infections, however, are more recent, and further epidemiologic studies for tracking this phenomenon are still warranted.
  9 in total

1.  Prevalence of genes encoding for members of the staphylococcal leukotoxin family among clinical isolates of Staphylococcus aureus.

Authors:  Christof von Eiff; Alexander W Friedrich; Georg Peters; Karsten Becker
Journal:  Diagn Microbiol Infect Dis       Date:  2004-07       Impact factor: 2.803

2.  Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles.

Authors:  Loren G Miller; Francoise Perdreau-Remington; Gunter Rieg; Sheherbano Mehdi; Josh Perlroth; Arnold S Bayer; Angela W Tang; Tieu O Phung; Brad Spellberg
Journal:  N Engl J Med       Date:  2005-04-07       Impact factor: 91.245

3.  Natural population dynamics and expansion of pathogenic clones of Staphylococcus aureus.

Authors:  Damian C Melles; Raymond F J Gorkink; Hélène A M Boelens; Susan V Snijders; Justine K Peeters; Michael J Moorhouse; Peter J van der Spek; Willem B van Leeuwen; Guus Simons; Henri A Verbrugh; Alex van Belkum
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

4.  Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients.

Authors:  Yves Gillet; Bertrand Issartel; Philippe Vanhems; Jean-Christophe Fournet; Gerard Lina; Michèle Bes; François Vandenesch; Yves Piémont; Nicole Brousse; Daniel Floret; Jerome Etienne
Journal:  Lancet       Date:  2002-03-02       Impact factor: 79.321

5.  Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia.

Authors:  G Lina; Y Piémont; F Godail-Gamot; M Bes; M O Peter; V Gauduchon; F Vandenesch; J Etienne
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

6.  Staphylococcus aureus isolates carrying Panton-Valentine leucocidin genes in England and Wales: frequency, characterization, and association with clinical disease.

Authors:  A Holmes; M Ganner; S McGuane; T L Pitt; B D Cookson; A M Kearns
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

7.  Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins.

Authors:  G Prevost; P Couppie; P Prevost; S Gayet; P Petiau; B Cribier; H Monteil; Y Piemont
Journal:  J Med Microbiol       Date:  1995-04       Impact factor: 2.472

8.  Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities.

Authors:  G Prévost; B Cribier; P Couppié; P Petiau; G Supersac; V Finck-Barbançon; H Monteil; Y Piemont
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

9.  Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence.

Authors:  Francois Vandenesch; Timothy Naimi; Mark C Enright; Gerard Lina; Graeme R Nimmo; Helen Heffernan; Nadia Liassine; Michèle Bes; Timothy Greenland; Marie-Elisabeth Reverdy; Jerome Etienne
Journal:  Emerg Infect Dis       Date:  2003-08       Impact factor: 6.883

  9 in total
  13 in total

1.  Unusual presentation of late-onset disseminated staphylococcal sepsis in a preterm infant.

Authors:  Shahzad Gul Khattak; Ian Dady; Devdeep Mukherjee
Journal:  BMJ Case Rep       Date:  2019-03-15

2.  Patients with Panton-Valentine leukocidin positive Staphylococcus aureus infections run an increased risk of longer hospitalisation.

Authors:  L Cupane; N Pugacova; D Berzina; V Cauce; D Gardovska; E Miklaševics
Journal:  Int J Mol Epidemiol Genet       Date:  2012-02-28

3.  Virulence Genes of Staphylococcus aureus Associated With Keratitis, Conjunctivitis, and Contact Lens-Associated Inflammation.

Authors:  Madeeha Afzal; Ajay Kumar Vijay; Fiona Stapleton; Mark Willcox
Journal:  Transl Vis Sci Technol       Date:  2022-07-08       Impact factor: 3.048

4.  Expression of Staphylococcal Virulence Genes In Situ in Human Skin and Soft Tissue Infections.

Authors:  Michael S Pulia; Jennifer Anderson; Zhan Ye; Noha S Elsayed; Thao Le; Jacob Patitucci; Krishna Ganta; Matthew Hall; Vineet K Singh; Sanjay K Shukla
Journal:  Antibiotics (Basel)       Date:  2022-04-14

5.  Unusually high prevalence of panton-valentine leukocidin genes among methicillin-sensitive Staphylococcus aureus strains carried in the Indonesian population.

Authors:  Juliëtte A Severin; Endang Sri Lestari; Kuntaman Kuntaman; Damian C Melles; Martijn Pastink; Justine K Peeters; Susan V Snijders; Usman Hadi; D Offra Duerink; Alex van Belkum; Henri A Verbrugh
Journal:  J Clin Microbiol       Date:  2008-04-23       Impact factor: 5.948

6.  Molecular epidemiology of Staphylococcus aureus in asymptomatic carriers.

Authors:  S Monecke; C Luedicke; P Slickers; R Ehricht
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-05-12       Impact factor: 3.267

Review 7.  Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era.

Authors:  Frank R DeLeo; Henry F Chambers
Journal:  J Clin Invest       Date:  2009-09       Impact factor: 14.808

8.  Linezolid has unique immunomodulatory effects in post-influenza community acquired MRSA pneumonia.

Authors:  Urvashi Bhan; Amy B Podsiad; Melissa A Kovach; Megan N Ballinger; Venkateshwar Keshamouni; Theodore J Standiford
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

9.  Factors predicting and reducing mortality in patients with invasive Staphylococcus aureus disease in a developing country.

Authors:  Emma K Nickerson; Vanaporn Wuthiekanun; Gumphol Wongsuvan; Direk Limmathurosakul; Pramot Srisamang; Weera Mahavanakul; Janjira Thaipadungpanit; Krupal R Shah; Arkhom Arayawichanont; Premjit Amornchai; Aunchalee Thanwisai; Nicholas P Day; Sharon J Peacock
Journal:  PLoS One       Date:  2009-08-04       Impact factor: 3.240

10.  Subpopulations of Staphylococcus aureus clonal complex 121 are associated with distinct clinical entities.

Authors:  Kevin Kurt; Jean-Philippe Rasigade; Frederic Laurent; Richard V Goering; Helena Žemličková; Ivana Machova; Marc J Struelens; Andreas E Zautner; Silva Holtfreter; Barbara Bröker; Stephen Ritchie; Sin Reaksmey; Direk Limmathurotsakul; Sharon J Peacock; Christiane Cuny; Franziska Layer; Wolfgang Witte; Ulrich Nübel
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.